Patents Assigned to Genexine Inc.
  • G-CSF immunoglobulin fusion proteins
    Patent number: 8586048
    Abstract: Disclosed are fusion proteins comprising a biologically active molecule and an immunoglobulin (Ig) Fc domain which is linked to the biologically active molecule. The Fc domain is a hybrid human Fc domain of (i) IgG1, IgG2 or IgG4 or (ii) IgG4 and IgD. The hybrid Fc is useful as a carrier of biologically active molecules.
    Type: Grant
    Filed: June 11, 2012
    Date of Patent: November 19, 2013
    Assignees: Genexine, Inc., Postech Academy-Industry Foundation
    Inventors: Sehwan Yang, Young Chul Sung
  • Human growth hormone immunoglobulin fusion proteins
    Patent number: 8529899
    Abstract: Disclosed are fusion proteins comprising a biologically active molecule and an immunoglobulin (Ig) Fc domain which is linked to the biologically active molecule. The Fc domain is a hybrid human Fc domain of (i) IgG1, IgG2 or IgG4 or (ii) IgG4 and IgD. The hybrid Fc is useful as a carrier of biologically active molecules.
    Type: Grant
    Filed: June 11, 2012
    Date of Patent: September 10, 2013
    Assignees: Genexine, Inc., Postech Academy-Industry Foundation
    Inventors: Sehwan Yang, Young Chul Sung
  • Vaccine enhancing the protective immunity to hepatitis c virus using plasmid DNA and recombinant adenovirus
    Patent number: 7989425
    Abstract: The present invention relates to a vaccine enhancing the protective immunity to Hepatitis C virus using plasmid DNA and recombinant adenovirus, more particularly to a vaccine consisting of ? core-E1-E2 expressing DNA vaccine, nonstructural protein NS3 and NS4 expressing DNA vaccine, nonstructural protein NS5 expressing DNA vaccine and recombinant adenovirus vaccine, and method for administration of the vaccine by priming with the DNA vaccines described above and boosting with the recombinant adenovirus vaccine thereby enhancing the protective immunity to Hepatitis C virus.
    Type: Grant
    Filed: September 24, 2003
    Date of Patent: August 2, 2011
    Assignees: Genexine Inc., Postech Foundation, Dong-A Pharm. Co., Ltd., Daewood Co., Ltd., Posco
    Inventors: Young Chul Sung, Jin-Won Youn, Se-Hwan Yang, Su-Hyung Park, Chang Geun Lee
  • Vaccine enhancing the protective immunity to hepatitis c virus using plasmid dna and recombinant adenovirus
    Publication number: 20050287117
    Abstract: The present invention relates to a vaccine enhancing the protective immunity to Hepatitis C virus using plasmid DNA and recombinant adenovirus, more particularly to a vaccine consisting of ?core-E1-E2 expressing DNA vaccine, nonstructural protein NS3 and NS4 expressing DNA vaccine, nonstructural protein NS5 expressing DNA vaccine and recombinant adenovirus vaccine, and method for administration of the vaccine by priming with the DNA vaccines described above and boosting with the recombinant adenovirus vaccine thereby enhancing the protective immunity to Hepatitis C virus.
    Type: Application
    Filed: September 24, 2003
    Publication date: December 29, 2005
    Applicants: Genexine Inc., Postech Foundation, Dong-A Pharm. Co., Ltd., Daewood Co., Ltd, Posco
    Inventors: Young Sung, Young Sung, Jin-won Youn, Se-Hwan Yang, Su-Hyung Park, Chang Lee